News

University of Queensland researchers are taking up the fight against one of the deadliest forms of breast cancer, developing next-generation nanoparticles to supercharge current treatments for triple-negative breast cancer.

The long-standing partnership between AIBN and Clarity Pharmaceuticals continues to thrive with the signing of a brand-new Supply Agreement for radionuclide, Copper-64.

New international research has its sights set on mosquito-borne neurotropic viruses, like dengue and Japanese Encephalitis, which are a growing global threat, with limited treatment options.

In the wake of the COVID-19 pandemic, new viral threats are considered an inevitability – particularly as our climate changes and, with it, human behaviour and demographics. For Emmanuel Hanon this means we need new ways to keep people healthy, and fast.

A newly discovered genomic immunity to an AIDs like retrovirus plaguing Australia’s koala population offers hope in the effort to save the beloved but endangered marsupial.

An update from the AIBN Director: Highlights from BioAsia 2025

University of Queensland researchers have developed an advanced sensor that can detect pregnancy complications as early as 11 weeks with a simple blood test – well before traditional screening methods.

AIBN researchers have turned to the most abundant organic compound on earth to help them transform a common weedkiller into a nano-herbicide that boosts plant hydration.

Our body’s complement system is aptly named, given the supporting role it plays in fighting disease and healing injuries.

The University of Queensland’s BASE facility – within the AIBN – and Brisbane-based biotechnology company Vaxxas have been announced as stage winners of a prestigious global prize to accelerate a patch-based mRNA vaccine for COVID-19.

AIBN researcher Dr Sophia Luikinga is following in the footsteps of her MND research mentor after winning a prestigious fellowship to address the neurodegenerative condition from a new angle.   

AIBN researchers say it is possible to mimic the biomechanical qualities of animals using a 3D printer – and they have instructions to show you how.

AIBN researchers have won vital funding to address the spread of cancer and develop new technology that could fight off the next pandemic.

Since 2004, the Australian Institute for Bioengineering and Nanotechnology (AIBN) has made a name for itself as the place that combines researchers, industry and government to solve the world’s biggest problems.

It’s smaller than a SIM card, made from gold, and can detect the earliest signs of disease in our blood.

A nanocoating that can halt viral outbreaks and new materials for solar cell and light emitting technology are among the cutting-edge AIBN projects to win funding in the latest Discovery Projects scheme.

New nanotechnology from the AIBN labs could help an emerging and non-invasive cancer treatment become even more effective.

You’ll find it in potatoes, bread, and rice, and maybe in a freshly ironed shirt. Now researchers from the AIBN are examining how starch could be a key ingredient in a new generation of bioplastics.

AIBN researchers have won funding to examine if particles in our muscles could unlock new treatments for Motor Neurone Disease.

Associate Professor Joy Wolfram has won funding to help patients bounce back more effectively after open-heart surgery.